Treatment of osteoporotic fracture.
D001846:Bone Development / Q000187:drug effects; D002118:Calcium / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004967:Estrogens / Q000627:therapeutic use; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology; D011446:Prospective Studies; D012008:Recurrence; D012306:Risk; D012969:Sodium Fluoride / Q000627:therapeutic use; D014807:Vitamin D / Q000378:metabolism / Q000627:therapeutic use
D004967:Estrogens; D014807:Vitamin D; D012969:Sodium Fluoride; D002118:Calcium